Fabiany da Costa Gonçalves, Ebru Demirci, & Alex Zwiers. (2022). A detailed analysis of expedited regulatory review time of marketing authorization applications for new anticancer drugs in the US and EU. Wiley.
Chicago Style (17th ed.) CitationFabiany da Costa Gonçalves, Ebru Demirci, and Alex Zwiers. A Detailed Analysis of Expedited Regulatory Review Time of Marketing Authorization Applications for New Anticancer Drugs in the US and EU. Wiley, 2022.
MLA (9th ed.) CitationFabiany da Costa Gonçalves, et al. A Detailed Analysis of Expedited Regulatory Review Time of Marketing Authorization Applications for New Anticancer Drugs in the US and EU. Wiley, 2022.
Warning: These citations may not always be 100% accurate.